Immatics (IMTX) Other Accumulated Expenses (2019 - 2025)

Immatics (IMTX) reported Other Accumulated Expenses of $6.5 million for Q4 2025, down 10.25% on a YoY basis from $7.3 million in Q4 2024, and up 21.45% sequentially from $5.4 million in Q3 2025.

Immatics (IMTX) Other Accumulated Expenses (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Other Accumulated Expenses data on file, last reported at $6.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses fell 10.25% year-over-year to $6.5 million; the trailing twelve-month figure through Dec 2025 stood at $6.5 million (down 10.25% YoY), and the FY2025 full-year result was $6.3 million, down 13.99% from the prior year.
  • Other Accumulated Expenses improved to $6.5 million in Q4 2025, from $5.4 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $16.6 million in Q3 2024 to a low of $1.7 million in Q1 2021.
  • A 5-year average of $6.7 million and a median of $7.1 million in 2024 frame the typical range for Other Accumulated Expenses.
  • Across the five-year window, Other Accumulated Expenses tumbled 85.38% in 2021 and jumped 377.4% in 2023, its largest moves.
  • Tracing IMTX's Other Accumulated Expenses over 5 years: stood at $2.9 million in 2021, then surged by 227.31% to $9.6 million in 2022, then advanced by 5.26% to $10.1 million in 2023, then dropped by 27.7% to $7.3 million in 2024, then slipped by 10.25% to $6.5 million in 2025.
  • Business Quant data shows IMTX's Other Accumulated Expenses at $6.5 million in Q4 2025, $5.4 million in Q3 2025, and $7.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,681.27 Bn 66,680.98 Bn -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 472.75 Bn 467.96 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.14 Bn 114.89 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn
10 Immatics 1.11 Bn 568.27 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 6.53 Mn
Sep 30, 2025 5.37 Mn
Jun 30, 2025 7.65 Mn
Mar 31, 2025 6.99 Mn
Dec 31, 2024 7.27 Mn
Sep 30, 2024 16.64 Mn
Jun 30, 2024 10.79 Mn
Mar 31, 2024 10.42 Mn
Dec 31, 2023 10.06 Mn
Sep 30, 2023 8.29 Mn
Jun 30, 2023 8.63 Mn
Mar 31, 2023 8.57 Mn
Dec 31, 2022 9.56 Mn
Sep 30, 2022 4.40 Mn
Jun 30, 2022 3.11 Mn
Mar 31, 2022 1.80 Mn
Dec 31, 2021 2.92 Mn
Sep 30, 2021 1.73 Mn
Jun 30, 2021 1.74 Mn
Mar 31, 2021 1.71 Mn